Diabetic Kidney Disease (DKD) Worsens CV Outcomes after First-Ever Major Cardiovascular Event in Type 2 Diabetes (T2D)

被引：0
|
作者：
Garofolo, Monia
Lucchesi, Daniela
Giambalvo, Massimo
Capobianco, Martina
Francesconi, Paolo
Penno, Giuseppe
Del Prato, Stefano
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-424-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
424-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cardiovascular (CV) Safety of Linagliptin in Patients With Type 2 Diabetes (T2D): A Pooled Comprehensive Analysis of Prospectively Adjudicated CV Events in Phase 3 Studies
    Johansen, Odd Erik
    Neubacher, Dietmar
    Seck, Thomas
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES, 2013, 62 : A96 - A96
  • [32] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S116 - S116
  • [33] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [34] Similar progression of diabetic retinopathy with glargine or NPH insulin in type 2 diabetes (T2D)
    Rosenstock, Julio
    Fonseca, Vivian
    McGill, Janet
    Riddle, Matthew
    Halle, Jean-Pierre
    Hramiak, Irene
    Johnston, Peter
    Davis, Matthew
    DIABETES, 2008, 57 : A86 - A86
  • [35] Type 2 diabetes (T2D), genetic susceptibility and the incidence of dementia in the cardiovascular health study
    Irie, F
    Fitzpatrick, AL
    Lopez, OL
    Peila, R
    Kuller, LH
    Newman, A
    Launer, LJ
    NEUROLOGY, 2005, 64 (06) : A316 - A316
  • [36] Level of Glycemic Control in Type 2 Diabetes (T2D) Patients with Established Cardiovascular Disease (eCVD) or Chronic Kidney Disease (CKD) Prescribed an SGLT2i
    Iglay, Kristy
    Bansal, Neha
    Gulati, Tania
    Hannachi, Hakima
    Fernandes, Gail
    Rajpathak, Swapnil
    DIABETES, 2019, 68
  • [37] Contemporary Practice Patterns and Opportunities to Improve Type 2 Diabetes (T2D) Therapy in Patients at Elevated Cardiovascular and/or Kidney Risk
    Blood, Alexander J.
    Chang, Lee-Shing
    Colling, Caitlin
    Stern, Gretchen
    Gabovitch, Dan
    Zelle, David
    Zacherle, Emily
    Noone, Josh
    Robar, Carey
    Matta, Lina
    Aronson, Samuel
    Gaziano, Thomas
    Plutzky, Jorge
    Cannon, Christopher P.
    Wexler, Deborah
    Scirica, Benjamin
    CIRCULATION, 2023, 148
  • [38] Independent Predictors of Cardiovascular Disease (CVD) Events Identified in a Cohort of Type 2 Diabetes (T2D) Patients in China
    Cai, Xiaoling
    Hu, Dayi
    Pan, Changyu
    Weng, Jianping
    Ji, Qiuhe
    Su, Benli
    Lu, Juming
    Tian, Haoming
    Li, Guangwei
    Zou, Dajin
    Zhang, Danyi
    Zhuo, Hanjing
    Ji, Linong
    DIABETES, 2015, 64 : A387 - A387
  • [39] Different Diabetic Kidney Disease (DKD) Phenotypes and Urinary Fetuin-A Levels in Subjects with Type 2 Diabetes
    Garofolo, Monia
    Lucchesi, Daniela
    Giambalvo, Massimo
    Capobianco, Martina
    Mancini, Gabriele
    Del Prato, Stefano
    Marchetti, Piero
    Penno, Giuseppe
    DIABETES, 2024, 73
  • [40] Association of Remnant Cholesterol (rem-C) with Kidney Disease Progression in People with Type 2 Diabetes (T2D)
    Yamamoto, Yui
    Hanai, Ko
    Mori, Tomomi
    Babazono, Tetsuya
    DIABETES, 2024, 73
12345